PT BrightGene Biomedical Indonesia is a research driven pharmaceutical company based in Indonesia that aims to be at the forefront as a developer and producer of high quality Active Pharmaceutical Ingredients (API) for the needs of the Indonesian pharmaceutical industry and for export to ASEAN markets.

PT BrightGene Biomedical Indonesia is a joint venture company established in 2018 between BrightGene Bio-Medical Technology Co., Ltd. (Suzhou, China) and experienced Indonesian pharmaceutical professionals. The plant is built on 25,000 sqm of land within Karawang New Industrial City (KNIC), a world-class integrated industrial estate close to Jakarta in Indonesia. State-of-art API manufacturing technologies that reduce the risks, timelines and costs in drug development have been incorporated into our plant in order to successfully manufacture generic and life-saving drug substance for Indonesia and export. 

Our Mission

We are committed to improving the availability of high-quality and affordable medicines in Indonesia that benefit patient outcomes and bring hope to families.

“We believe that strong partnerships have the power to spark innovation and impact lives positively”

Dr. Yuan, Jian Dong (Ph.D.)
Founder of BrightGene Bio-Medical Technology Co., Ltd.

“We aim to be one of the pioneers in Indonesia in producing APIs with the aim of reducing the reliance of imported drugs and supporting the competitiveness of the national pharmaceutical industry.”

Mr. Johannes Setijono
Commissioner of PT BrightGene